Literature DB >> 20659485

Albuminuria and VEGF as early markers of cardiovascular disturbances in young type 1 diabetic patients.

Dariusz Naskret1, Dorota A Zozulinska-Ziolkiewicz, Rafal Dankowski, Henryk Wysocki, Bogna Wierusz-Wysocka.   

Abstract

AIMS: The aim of the study was to assess myocardial perfusion by means of non-invasive diagnostic methods and measurement of the plasma concentration of vascular endothelial growth factor (VEGF) in patients with long-lasting type 1 diabetes. METHODS AND
RESULTS: The study was performed on 41 Type 1 diabetic patients (23 females, 18 males), aged 30±7.6 with a duration of disease 15.2±5.5years. 17 patients exhibited microalbuminuria (10 females, 7 males) and 24 subjects were without microalbuminuria (13 females, 11 males). The methods used included a 24-h ECG tape, an exercise treadmill test, echocardiological evaluation with dobutamine and atropine challenge and single photon emission computer tomography (SPECT) at rest, and after dipyridamol induction of ischemia. All the exercise and stress echocardiography tests were negative. There were significant differences between microalbuminuric and normoalbuminuric subjects in the duration of their exercise tests (586.9±110.5 vs. 664.9±133.2s, p=0.027), performed work (11.4±1.6.vs. 12.6±1.8 METs, p=0.045), achieved pulse limit (89.1±3.6 vs. 92.6±5.2%, p=0.037), rest ejection fraction (55.8±8.7 vs. 62.0±4.4%, p=0.040), abnormal changes in SPECT (53 vs. 21%, p=0.047) and VEGF concentration (101.5±7.8 vs. 75.15±16.5pg/ml, p<0.05). The presence of retinopathy increased 12-fold the probability of significant changes in the SPECT (OR 12.1, 95% CI 1.38-105.64, p=0.02) and nephropathy (OR 4.27; 95%CI 1.09-16.83, p=0.03).
CONCLUSION: Asymptomatic patients with long lasting type 1 diabetes may have disturbances in myocardial perfusion, especially these with microalbuminuria.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659485     DOI: 10.1016/j.mvr.2010.07.009

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  3 in total

1.  Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects.

Authors:  A Esteghamati; A Arefzadeh; A Zandieh; M Salehi Sadaghiani; S Noshad; M Nakhjavani
Journal:  J Endocrinol Invest       Date:  2013 Jul-Aug       Impact factor: 4.256

2.  Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype.

Authors:  Veronica Tisato; Giorgio Zauli; Rebecca Voltan; Sergio Gianesini; Maria Grazia di Iasio; Ilaria Volpi; Guido Fiorentini; Paolo Zamboni; Paola Secchiero
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

3.  Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β, angiotensinogen expression and podocytes apoptosis through the nuclear factor-κB pathway.

Authors:  Lijuan Xu; Pengyuan Zhang; Hongyu Guan; Zhimin Huang; Xiaoying He; Xuesi Wan; Haipeng Xiao; Yanbing Li
Journal:  J Diabetes Investig       Date:  2016-04-01       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.